SEOUL, Oct. 28 (Yonhap) -- Yuhan Corp., a South Korean biopharmaceutical company, said Monday its third-quarter net profit ...

Yuhan-Kimberly, a joint venture between Korea’s Yuhan Corp. and America’s Kimberly Clark, has been chosen as one of the ...

The U.S. drugmaker has “mutually agreed” to terminate its collaboration and license agreement with South Korean biotech Yuhan for a pair of MASH therapies. It means Gilead has lost the $15 ...

Yuhan stands to potentially receive up to $1.25 billion in potential development and commercial milestone payments, along with tiered double-digit royalties on future net sales.

Gilead Sciences has abandoned a liver disease collaboration with Yuhan. A new study suggests Leqembi's vial design could cost Medicare hundreds of millions of dollars in waste each year.

Reporting in the journal Nature, Caltech-led researchers have uncovered where FRBs are more likely to occur in the ...

J INTS BIO will oversee the entire project, managing clinical trials to validate AI-based predictions and develop clinically ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Huang, Yuhan. "Gender, Ideology, and Nationalism in Chinese Children’s Cinema." The Oxford Handbook of Children's Film. Ed. Noel Brown. New York, New York: Oxford ...

Yuhan Li is Associate Director of Learning Design in the Center for Digital Innovation in Learning at Boston College. With nearly 8 years of experience supporting faculty teaching in higher education, ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.